Results
The trial was terminated early because of highly significant reduction in mortality in the poractant alfa group.
Mortality data was analysed for 199 neonates:
- in the Porcactant alpha group mortality was 14.1%
- in the Pumactant group mortality was 31%
- p=0.006
Create an account to add page annotations
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page